Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Product News
Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

AB SCIEX Announces Immunosuppressants Kit for Use by Doctors in Europe to Help Care for Organ Transplant Patients
Friday, April 04, 2014
The SCIEX IVD-MS™ Immunosuppressants kit is designed to give clinicians fast, accurate information about the level of immunosuppressant drug circulating in a patient’s body.

EMD Millipore Launches New Kits for Use on Gyros’ Immunoassay Platform
Wednesday, March 26, 2014
Ready-to-use kits are fully qualified for reliable use in clinical research.

Merck Millipore Launches New Immunoassay Kits
Tuesday, March 25, 2014
Ready-to-use kits are fully qualified for reliable use in clinical research.

ChromaTrap Receives Positive Commentary in Cited Research
Thursday, March 20, 2014
Researchers cite how using the fast, sensitive ChIP technology has benefited their research.

QIAGEN Launches QuantiFERON-TB Gold In-Tube in China
Thursday, March 20, 2014
Pioneering blood test that accurately identifies people infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis.

Molecular Devices to Showcase Next Generation SpectraMax® MiniMax™ 300 Imaging Cytometer at Analytica
Wednesday, March 19, 2014
SpectraMax® MiniMax™ 300 imaging cytometer enables both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax®i3 Multi-Mode Microplate Reader.

New JA-14.50 Rotors from Beckman Coulter Life Sciences
Friday, March 14, 2014
High performance unit supports full range of common tubes.

Bio-Rad Introduces ReadiLink Antibody Labeling Kits
Tuesday, March 11, 2014
ReadiLink antibody labeling kits are one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50–100 µg) of antibody.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 385
Scientific News
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Freshly Squeezed Vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
New Target for Treating Rheumatoid Arthritis
Many affected individuals still suffer with progressive joint damage, despite treatment. This study has discovered a new treatment target which could open a door to preventing this ongoing damage.
Shining A New Light On The Immune System
Scientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with “molecular fingerprints” which could pave the way for the rapid detection of conditions such as leukaemia and lymphoma from a small blood sample.
Promising Malaria and Dengue Vaccines Will Not Defeat Diseases
Although vaccination is a key part of the control of disease GlobalData stress the importance of a multi-dimensional approach.
'Redesigned' Antibodies May Neutralize HIV
With the help of a new computer program researchers have made structural alterations to an antibody, increasing its ability to tackle the AIDS virus.
How Early Childhood Vaccination Reduces Leukemia Risk
Chronic infections push ‘pre-leukemia’ cells, common in newborns, into malignancy.
Novel Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis
Researchers hope that they can end the global TB crisis by utilizing a novel bactericidal mechasnism.
Inflammation Stops The Clock
Researchers at Trinity College Dublin and the University of Pennsylvania have uncovered an important link between our body clock and the immune system that will have relevance to the treatment of inflammatory and infectious diseases.
Designing Better Medical Implants
A team of MIT researchers have discovered a novel method for reducing the typical immune system rejection response when implanting biomedical devices into the body.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters